- /
- Supported exchanges
- / US
- / QNCX.NASDAQ
Quince Therapeutics, Inc. (QNCX NASDAQ) stock market data APIs
Quince Therapeutics, Inc. Financial Data Overview
Quince Therapeutics, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases. The company's lead asset candidature comprises EryDex for the treatment of rare pediatric neurodegenerative disease, including A-T, an inherited autosomal recessive neurodegenerative and immunodeficiency disorder caused by mutations in ATM gene. Its AIDE technology platform, a drug/device combination platform that uses an automated process to encapsulate a drug into a patient's own red blood cells, as well as consists of an automated equipment the RCL, a sterile single-use consumable treatment kit comprising kit medical devices, syringe kit, and process solutions. The company was formerly known as Cortexyme, Inc. and changed its name to Quince Therapeutics, Inc. in August 2022. The company was incorporated in 2012 and is headquartered in South San Francisco, California.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Quince Therapeutics, Inc. (top by weight)
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Quince Therapeutics, Inc. data using free add-ons & libraries
Get Quince Therapeutics, Inc. Fundamental Data
Quince Therapeutics, Inc. Fundamental data includes:
- Net Revenue:
- EBITDA: -50 287 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
Get Quince Therapeutics, Inc. Earnings data
Corporate Events Calendar & News package for
What’s included:
- Latest Release: 2026-03-03
- EPS/Forecast: -0.1833
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Quince Therapeutics, Inc. News
New
Quince Therapeutics clears $16M EIB debt; shares surge 18%
* Quince Therapeutics (QNCX [https://seekingalpha.com/symbol/QNCX]) settled its outstanding ~$16.4M EIB loan [https://seekingalpha.com/pr/20455197-quince-therapeutics-settles-approximately-16_4-mill...
BC-Most Active Stocks
NEW YORK (AP) — prices for the Nasdaq composite, NYSE and NYSE American listed most active stocks. Nasdaq most active stocks: Stock Name Volume High Low Last Change Kala Bio Inc. 192,018,255 0.51 ...
BC-Most Active Stocks
NEW YORK (AP) — prices for the Nasdaq composite, NYSE and NYSE American listed most active stocks. Nasdaq most active stocks: Stock Name Volume High Low Last Change Blue Hat Interac.Entert.Techn. ...
BC-Most Active Stocks
NEW YORK (AP) — prices for the Nasdaq composite, NYSE and NYSE American listed most active stocks. Nasdaq most active stocks: Stock Name Volume High Low Last Change Classover Holdings Inc. 225,318...
Corporate Events Calendar & News package for
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.